Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 2 | 2023 | 296 | 1.180 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 264 | 1.180 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 33 | 0.820 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.710 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2020 | 28 | 0.690 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 42 | 0.660 |
Why?
|
| Cytodiagnosis | 1 | 2019 | 46 | 0.640 |
Why?
|
| Phyllodes Tumor | 1 | 2018 | 7 | 0.620 |
Why?
|
| Papillomaviridae | 1 | 2019 | 156 | 0.600 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 1744 | 0.570 |
Why?
|
| Mutation | 3 | 2019 | 4168 | 0.480 |
Why?
|
| Epithelial Cells | 2 | 2018 | 689 | 0.470 |
Why?
|
| Anastomotic Leak | 2 | 2013 | 104 | 0.470 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1545 | 0.460 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2013 | 203 | 0.450 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 64 | 0.400 |
Why?
|
| Intestines | 2 | 2012 | 416 | 0.350 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 52 | 0.340 |
Why?
|
| Neuroendocrine Tumors | 2 | 2022 | 124 | 0.340 |
Why?
|
| Colectomy | 1 | 2010 | 175 | 0.320 |
Why?
|
| Cross Infection | 1 | 2010 | 151 | 0.320 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 376 | 0.280 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 422 | 0.280 |
Why?
|
| Phospholipases A | 1 | 2006 | 45 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 684 | 0.260 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 100 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2415 | 0.230 |
Why?
|
| Thyroid Nodule | 1 | 2024 | 62 | 0.220 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 67 | 0.210 |
Why?
|
| Thyroid Gland | 1 | 2024 | 280 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 105 | 0.200 |
Why?
|
| Phosphates | 2 | 2012 | 161 | 0.190 |
Why?
|
| Anastomosis, Surgical | 2 | 2013 | 277 | 0.190 |
Why?
|
| Colonic Pouches | 1 | 2022 | 85 | 0.180 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2022 | 105 | 0.180 |
Why?
|
| Humans | 15 | 2024 | 89968 | 0.180 |
Why?
|
| Inflammation | 3 | 2022 | 981 | 0.180 |
Why?
|
| Celiac Disease | 1 | 2023 | 214 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2018 | 458 | 0.180 |
Why?
|
| Injections | 1 | 2020 | 116 | 0.170 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 17 | 0.160 |
Why?
|
| Diclofenac | 1 | 2018 | 4 | 0.160 |
Why?
|
| Biopsy | 2 | 2023 | 1184 | 0.160 |
Why?
|
| L-Selectin | 1 | 2018 | 16 | 0.160 |
Why?
|
| Metaplasia | 1 | 2018 | 37 | 0.150 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 177 | 0.150 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2019 | 80 | 0.150 |
Why?
|
| GATA3 Transcription Factor | 1 | 2018 | 48 | 0.150 |
Why?
|
| Kallikreins | 1 | 2018 | 46 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 665 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2018 | 101 | 0.150 |
Why?
|
| Triage | 1 | 2019 | 117 | 0.150 |
Why?
|
| Leukocytes | 1 | 2018 | 209 | 0.140 |
Why?
|
| Endoscopy | 1 | 2020 | 352 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2019 | 443 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 244 | 0.130 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 338 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1801 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 490 | 0.130 |
Why?
|
| Phenotype | 4 | 2022 | 2458 | 0.130 |
Why?
|
| Male | 9 | 2024 | 42680 | 0.130 |
Why?
|
| Crohn Disease | 1 | 2022 | 764 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 760 | 0.120 |
Why?
|
| Genotype | 1 | 2019 | 1853 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 806 | 0.110 |
Why?
|
| Middle Aged | 4 | 2024 | 26148 | 0.110 |
Why?
|
| Caenorhabditis elegans | 2 | 2012 | 231 | 0.110 |
Why?
|
| Radiation | 1 | 2012 | 15 | 0.100 |
Why?
|
| Models, Biological | 2 | 2013 | 1765 | 0.100 |
Why?
|
| Adult | 5 | 2024 | 26822 | 0.100 |
Why?
|
| Female | 6 | 2024 | 46594 | 0.100 |
Why?
|
| Protective Agents | 1 | 2012 | 34 | 0.100 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.100 |
Why?
|
| Apoptosis | 2 | 2012 | 1718 | 0.100 |
Why?
|
| Candida albicans | 1 | 2012 | 32 | 0.100 |
Why?
|
| Rats, Wistar | 1 | 2012 | 303 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 150 | 0.090 |
Why?
|
| DNA Repair | 2 | 2022 | 363 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3024 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 237 | 0.090 |
Why?
|
| Metagenome | 1 | 2011 | 105 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 360 | 0.090 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2010 | 44 | 0.090 |
Why?
|
| Wound Healing | 1 | 2012 | 361 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 192 | 0.080 |
Why?
|
| Rats | 2 | 2013 | 4048 | 0.080 |
Why?
|
| Critical Illness | 1 | 2012 | 311 | 0.080 |
Why?
|
| Colon | 1 | 2012 | 521 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 2329 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2010 | 298 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 1102 | 0.080 |
Why?
|
| Aged | 3 | 2024 | 19254 | 0.070 |
Why?
|
| Mesons | 1 | 2007 | 9 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2010 | 166 | 0.070 |
Why?
|
| Color | 1 | 2007 | 85 | 0.070 |
Why?
|
| Hippocampus | 1 | 2010 | 449 | 0.070 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 44 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2006 | 64 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 591 | 0.060 |
Why?
|
| Netropsin | 1 | 2004 | 1 | 0.060 |
Why?
|
| Acetaldehyde | 1 | 2004 | 7 | 0.060 |
Why?
|
| Mutagens | 1 | 2004 | 31 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 2004 | 25 | 0.060 |
Why?
|
| Animals | 6 | 2018 | 27528 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2024 | 107 | 0.060 |
Why?
|
| Adenine | 1 | 2004 | 88 | 0.060 |
Why?
|
| Astrocytes | 1 | 2004 | 142 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 83 | 0.050 |
Why?
|
| Duodenum | 1 | 2023 | 105 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 490 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2018 | 2015 | 0.050 |
Why?
|
| Cerebellum | 1 | 2004 | 250 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2022 | 22 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 51 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 78 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 3252 | 0.050 |
Why?
|
| 5-Methylcytosine | 1 | 2022 | 117 | 0.050 |
Why?
|
| Child | 2 | 2023 | 7244 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2024 | 425 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2393 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 352 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1244 | 0.040 |
Why?
|
| Mice | 4 | 2018 | 11851 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 521 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 122 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2767 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 3680 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 5359 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1732 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2013 | 26 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1352 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2013 | 84 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 120 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 34 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 99 | 0.020 |
Why?
|
| Biofilms | 1 | 2012 | 46 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 24 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 996 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 142 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2011 | 73 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2010 | 9 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2010 | 20 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2362 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 127 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 333 | 0.020 |
Why?
|
| Hand Strength | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 199 | 0.020 |
Why?
|
| Neurons | 2 | 2010 | 1591 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5559 | 0.020 |
Why?
|
| General Surgery | 1 | 2011 | 236 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6783 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 869 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 232 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 899 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 9210 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 327 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2887 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1158 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 6410 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9342 | 0.020 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2004 | 1 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 493 | 0.010 |
Why?
|
| Alkylating Agents | 1 | 2004 | 32 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 108 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 194 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 388 | 0.010 |
Why?
|